LASIK and multifocal IOLs superior to accommodative IOL for treating presbyopia

Article

PresbyLASIK or multifocal IOL implantation yield superior visual outcomes in patients with presbyopia, improving both near and distance vision, as opposed to accommodative IOL implantation, which improves distance vision only, according to a study published in the March 2008 issue of the Journal of Refractive Surgery.

PresbyLASIK or multifocal IOL implantation yield superior visual outcomes in patients with presbyopia, improving both near and distance vision, as opposed to accommodative IOL implantation, which improves distance vision only, according to a study published in the March 2008 issue of the Journal of Refractive Surgery.

Sudi Patel of the Vissum Instituto Oftalmológico de Alicante, Spain and researchers compared the visual outcomes of a multifocal IOL (Acri.Smart; Acri.Tec/Zeiss) and an accommodative lens (AT-45; Crystalens/Bausch & Lomb) for the correction of distance and near visual acuity (VA) with a LASIK procedure for presbyopia (presbyLASIK) and a control group fitted with a standard distance-correcting monofocal IOL (AcrySof; Alcon).

Distance and near decimal visual acuities were measured under similar conditions pre- and six months postoperatively in 45 patients (87 eyes). All acuity measures were standardized at 20 m (distance, projected chart) and 40 cm (near).

Preoperatively, the team recorded distance mean VAs of 0.15±0.21, 0.31±0.14, 0.35±0.15 and 0.32±0.18 for the Acri.Smart, AT-45, presbyLASIK and control groups, respectively. Postoperatively, this was 0.66±0.35, 0.68±0.28, 0.80±0.33 and 0.59±0.29 for each of the respective groups. In terms of near mean VAs, the team recorded preoperative figures of 0.13±0.21, 0.43±0.22, 0.15±0.20 and 0.40±0.29 for the Acri.Smart, AT-45, presbyLASIK and control groups, respectively. Postoperatively, this was 0.62±0.35, 0.51±0.27, 0.68±0.33 and 0.30±0.13 for each of the respective groups. Distance and near visual acuities improved significantly after surgery (p<0.05) except near acuities for the AT-45 IOL and control groups.

The study demonstrated that distance and near acuities improved with presbyLASIK and Acri.Smart IOLs when compared with monofocal IOLs. In those patients treated with the accommodative AT-45 IOL, average distance VA improved but not near VA.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.